logo

For the Inventor, By the Inventor

Kyoto, Japan

Yoshitaka Maki

USPTO Granted Patents = 16

Average Co-Inventor Count = 2.1

ph-index = 10

Forward Citations = 452(Granted Patents)


Location History:

  • Highland Park, IL (US) (1989)
  • Kyoto, JP (1982 - 1994)

Company Filing History:

goldMedal16 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1982-1994

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5304658 - Quinone derivatives, their production and use (1994-04-19),
2. 5180742 - Quinone derivatives, their production and use (1993-01-19),
3. 4857516 - Coumaran derivatives and their pharmaceutical use (1989-08-15),
4. 4769456 - Sulfenamide derivatives and their production (1988-09-06),
5. 4738975 - Pyridine derivatives, and use as anti-ulcer agents (1988-04-19),
6. 4727150 - Pyridyl methylsulfinyl benzimidazole derivatives (1988-02-23),
7. 4714774 - Benzoic acid derivatives and their production (1987-12-22),
8. 4689333 - 2-(2-pyridylmethylthio (sulfinyl)) benzimidazoles (1987-08-25),
9. 4672073 - Diphenoxypropane derivatives, its production and use 5-tetrazolyl (1987-06-09),
10. 4628098 - 2-[2-pyridylmethylthio-(sulfinyl)]benzimidazoles (1986-12-09),
11. 4612321 - 5-pyridyl-1,3-thiazole derivatives (1986-09-16),
12. 4603203 - 3-aminopyrazolo[3,4-d]pyrimidine derivatives and production thereof (1986-07-29),
13. 4567201 - Diphenoxypropane derivatives and compositions of antiasthmatic and (1986-01-28),
14. 4489096 - Quinone compounds, their production and use (1984-12-18),
15. 4393075 - Quinone compounds and their use in suppressing the production of SRS-A (1983-07-12),

Title: **Yoshitaka Maki: Pioneering Innovations in Quinone Derivatives**

Introduction

Yoshitaka Maki, an accomplished inventor based in Kyoto, Japan, has made significant strides in the field of chemistry with a total of 16 patents to his name. His innovative contributions focus on the development of quinone derivatives, which hold promising therapeutic potential.

Latest Patents

Maki’s latest patents revolve around novel quinone derivatives, specifically their production and use. These compounds are characterized by a complex structural formula that includes customizable elements such as methyl and methoxy groups, varying aliphatic, aromatic, or heterocyclic groups, and specific configurations for metabolic activity. The quinone derivatives exhibit metabolism ameliorating actions for polyunsaturated fatty acids, particularly demonstrating antioxidant activity by inhibiting the production of lipid peroxides. Moreover, they display thromboxane A2 receptor antagonism and inhibit the production of 5-lipoxygenase metabolites in mammals, indicating their potential utility as therapies for conditions such as asthma and allergic reactions, as well as agents to improve cerebral-circulatory metabolism.

Career Highlights

Maki has established himself within the pharmaceutical industry by bringing innovative solutions and new compounds to the forefront. He is currently associated with Takeda Chemical Industries, Inc., where his research continues to influence advancements in drug development and therapeutic applications.

Collaborations

Throughout his career, Maki has collaborated with notable colleagues, including Akira Nohara and Shinji Terao. Their collective efforts have fostered a dynamic research environment, promoting knowledge exchange and facilitating breakthroughs in medicinal chemistry.

Conclusion

Yoshitaka Maki’s contributions to the field of chemistry, particularly in the realm of quinone derivatives, highlight his ingenuity and commitment to advancing scientific knowledge. His extensive patent portfolio and ongoing research efforts at Takeda Chemical Industries, Inc. position him as a vital figure in the pursuit of innovative therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…